Market by Device Type, Application, Detection and Prediction Device Type, End-user, and Regional Outlook | Forecast 2022-2028
According to the World Health Organization
(WHO), epilepsy affects about 50 million people globally and constitutes a
sizable share of the global disease burden. Estimates indicate that epilepsy
affects 49 out of every 100,000 people in high-income nations. Recurrent
seizures, involving brief episodes of involuntary movement of the entire body
or certain parts of the body, are consistent with the chronic, non-communicable
brain disease epilepsy. With the right diagnosis and the use of affordable,
widely accessible anti-seizure medications, approximately 70% of patients with
epilepsy could be successfully treated.
According to Triton Market Research’s report, the Global Epilepsy Devices Market was valued at $669.73 million in 2021 and is expected to reach $1157.58 million by 2028, growing at a CAGR of 8.16% during the forecast period 2022-2028.
Click here to check out our blog on the Global Epilepsy Devices Market
MARKET PERFORMANCE: DRIVERS,
CHALLENGES, AND TRENDS
Over
the forecast period, combating epilepsy through early detection and diagnosis
and rising global occurrences of epilepsy are expected to boost the studied
market’s expansion. Technologies
such as point-of-care systems (POCs) are employed in the early identification,
diagnosis, or treatment of a clinical condition to achieve a positive outcome.
POCs are small, lightweight epilepsy devices that the patient can carry around.
Also, due to their higher risk of accidental injuries than the general
population, people diagnosed with epilepsy can take the required precautions to
prevent secondary injuries. Increased risk of endemic diseases like
neurocysticercosis or malaria, rise in birth-related injuries and traffic
accidents, discrepancies in medical infrastructure, and lack of preventive
health programs will further drive the epilepsy devices market.
The
market; however, might be restricted due to challenges like unawareness about
epilepsy among the general masses as well as inadequate neurology specialists
in the healthcare system. Epilepsy
and seizures have long been the subject of misunderstandings passed down
through the generations. The false knowledge has fuelled prejudice and
discrimination against those diagnosed with epilepsy, interfering with their
capacity to work and lead active social lives. Public comprehension and
awareness of a medical condition and experienced health professionals are
essential for prevention, early intervention, and community acceptance of
modern medicine. And thus, the lack of these factors contributes to the
significant treatment gap for epilepsy across various developing nations.
Nevertheless, emerging research and development due to the growing emergence of epilepsy among the senior population, ascending post-traumatic epilepsy (PTE) cases due to brain injuries, and technological advances in non-invasive wearable sensors are expected to generate opportunities for the studied market. The ability to detect seizure-related alterations may be enabled by advancements in non-invasive wearable sensors that measure photoplethysmography (PPG), accelerometer, electrodermal activity (EDA), electromyography (EMG), and other signals outside the conventional clinical environment. Recent research employing long-term wearable technology and electronic seizure logs has generated encouraging results for probable seizure risk predictions. A person’s symptoms, mood, and cognitive ability may also be useful predictors. User approval of the procedure is much more important since seizure forecasting requires continuous monitoring.
Report scope can be customized per your requirements - Request Free Sample Report
KEY
GEOGRAPHIES COVERED:
● North America: United States and Canada
● Europe: United Kingdom, France, Germany, Spain, Italy, and Rest of Europe
● Asia-Pacific: China, Japan, India, Australia & New Zealand, South Korea, ASEAN Countries, and Rest of Asia-Pacific
● Latin America: Brazil, Mexico, and Rest of Latin America
●
Middle East and Africa: Saudi Arabia, Turkey, United Arab
Emirates, South Africa, and Rest of Middle East & Africa
SEGMENTATION ANALYSIS -
EPILEPSY DEVICES MARKET:
• Market by Device Type:
o Traditional
Devices
Equipment for recording electroencephalograms (EEG) is one of the most
important paraclinical methods to diagnose epilepsy. In fact, recording an EEG
seizure provides the most conclusive proof of epilepsy and enables a
fine-grained electroclinical characterization, which frequently has
consequences for diagnostic and therapeutic purposes. The use of traditional
devices, the increasing need for epilepsy surveillance in clinical studies, the
availability of reimbursement for EEG therapies in developed countries,
screening and education campaigns, and epilepsy treatment at an affordable
price are key factors contributing to the segment’s growth.
o Wearable
Devices
• Watches
• Bracelets
• Camera Devices
• Mattress Devices
• Anti-Suffocation Pillows
• Other Wearable Devices
o Implantable
Devices
• Market by Application:
o Vagus
Nerve Stimulation
VNS therapy, known as vagus nerve stimulation, has received US
government approval. Known as drug-resistant epilepsy or refractory epilepsy,
VNS therapy is employed as add-on therapy and is approved by the FDA to treat
focal or partial seizures that do not respond to seizure drugs in adults and
children aged 4 and older. Despite the rarity of total seizure independence,
VNS therapy may help lower seizure frequency and enhance the quality of life.
VNS has proven helpful for various individuals, including those diagnosed with
posttraumatic epilepsy (PTE).
o Deep
Brain Stimulation
• Movement disorders
• Epilepsy
o Accelerometer
o Responsive
Neurostimulation
• Market by Detection and Prediction Device Type:
o Electroencephalogram
o Intracranial
EEG
o Surface
Electromyography
o Electrocardiography
o Video
Detection Systems
o Electrodermal
Activity
o Implanted
Advisory Systems
o Other
Detection and Prediction Device Types
• Market by End-user:
o Hospitals
and Clinics
o Home
Care Settings
o Other
End-users
COMPETITIVE LANDSCAPE:
The epilepsy devices market by company profile
helps dive into data about the key players in this industry. The strategic
initiatives for each of the companies considered have been covered in detail.
Development (September 2022):
Boston Scientific Corporation
The US Food and Drug Administration (FDA)
authorised the WATCHMAN FLXTM Left Atrial Appendage Closure (LAAC) Device
manufactured by Boston Scientific Corporation to increase the directions for
use labelling.
Collaboration
(August 2022): Medtronic PLC and BioIntelliSense
A strategic partnership between Medtronic PLC
and BioIntelliSense was announced in August 2022 for the exclusive
rights for BioButton® multi-parameter wearable. This collaboration gives
various hospitals, including the 30-day post-acute hospitals, the home
distribution rights for continuous, connected monitoring, which evaluates a
patient’s vital signs consistently during their stay in the hospital and
post-discharge.
Acquisition
(June 2020): Medtronic PLC and Affera Inc
With the acquisition of Affera Inc, Medtronic
PLC added its first-ever cardiac mapping and navigation platform to its
portfolio of cardiac ablation technologies. This platform combines a
distinctive, fully integrated diagnostic focal pulsed field and
radiofrequency ablation solution.
KEY BENEFITS OF THE REPORT:
●
Triton Market Research has a collective experience of 25-30 years
in the industry, with its analysts and experts encompassing the most infallible
research methodology for its market intelligence and industry analysis.
●
Our research methodology helps in achieving a broader consensus of
the market size, shape, and industry trends within each industry segment.
●
The strategy adopted in designing the research methodology
includes the amalgamation of the information assembled from primary and
secondary sources, with the assistance of analytical tools to construct the
forecast and predictive models.
●
The scope of the market report comprises the current scenario of
the global application security market, along with the detailed overview of the
industry outlook, market dynamics, segmentation analysis, regional outlook, and
competitive landscape for the period 2022-2028.
FAQs:
Q 1) What is the biggest
challenge for the epilepsy devices market?
The misperceptions and the stigma attached to epilepsy disorders pose a
major challenge for the epilepsy devices market.
Q 2) Which promising end-use
might be a key investment pocket for the epilepsy devices market?
Technological advancements in non-invasive wearable devices that employ
electrodermal activity (EDA), electromyography (EMG), and other signals are
promising end-uses for epilepsy devices.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
EPILEPSY DEVICES MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE EPILEPSY DEVICES MARKET
2.2. KEY
INSIGHTS
2.2.1. GROWING
USE OF TELEMEDICINE SERVICES
2.2.2. INCREASE
IN DRUG AND DEVICE TRIALS FOR EPILEPSY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
BUYING IMPACT ANALYSIS
2.4.1. COMFORT
& USABILITY
2.4.2. PRODUCT
FEATURES
2.4.3. CONFIDENTIALITY
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. DEVELOPMENTS
& PRODUCT LAUNCHES
2.9.2. COLLABORATIONS
2.9.3. ACQUISITIONS
2.10. MARKET
DRIVERS
2.10.1. COMBATING
EPILEPSY THROUGH EARLY DETECTION AND DIAGNOSIS
2.10.2. RISING
PREVALENCE OF EPILEPSY
2.11. MARKET
CHALLENGES
2.11.1. UNAWARENESS
ABOUT EPILEPSY AMONG THE GENERAL MASSES
2.11.2. LACK
OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM
2.12. MARKET
OPPORTUNITIES
2.12.1. R&D
ACTIVITIES DUE TO GROWING EPILEPSY CASES IN OLD PEOPLE
2.12.2. ASCENDING
POST-TRAUMATIC EPILEPSY (PTE) CASES DUE TO BRAIN INJURIES
2.12.3. TECHNOLOGICAL
ADVANCES IN NON-INVASIVE WEARABLE SENSORS
3. GLOBAL
EPILEPSY DEVICES MARKET OUTLOOK - BY DEVICE TYPE
3.1. TRADITIONAL
DEVICES
3.2. WEARABLE
DEVICES
3.2.1. WATCHES
3.2.2. BRACELETS
3.2.3. CAMERA
DEVICES
3.2.4. MATTRESS
DEVICES
3.2.5. ANTI-SUFFOCATION
PILLOWS
3.2.6. OTHER
WEARABLE DEVICES
3.3. IMPLANTABLE
DEVICES
4. GLOBAL
EPILEPSY DEVICES MARKET OUTLOOK - BY APPLICATION
4.1. VAGUS
NERVE STIMULATION
4.2. DEEP
BRAIN STIMULATION
4.2.1. MOVEMENT
DISORDERS
4.2.2. EPILEPSY
4.3. ACCELEROMETER
4.4. RESPONSIVE
NEUROSTIMULATION
5. GLOBAL
EPILEPSY DEVICES MARKET OUTLOOK - BY DETECTION AND PREDICTION DEVICE TYPE
5.1. ELECTROENCEPHALOGRAM
5.2. INTRACRANIAL
EEG
5.3. SURFACE
ELECTROMYOGRAPHY
5.4. ELECTROCARDIOGRAPHY
5.5. VIDEO
DETECTION SYSTEMS
5.6. ELECTRODERMAL
ACTIVITY
5.7. IMPLANTED
ADVISORY SYSTEMS
5.8. OTHER
DETECTION AND PREDICTION DEVICE TYPES
6. GLOBAL
EPILEPSY DEVICES MARKET OUTLOOK - BY END-USER
6.1. HOSPITALS
& CLINICS
6.2. NEUROLOGY
CENTERS
6.3. HOMECARE
SETTINGS
6.4. OTHER
END-USERS
7. GLOBAL
EPILEPSY DEVICES MARKET – REGIONAL OUTLOOK
7.1. NORTH
AMERICA
7.1.1. MARKET
BY DEVICE TYPE
7.1.1.1. MARKET
BY WEARABLE DEVICES
7.1.2. MARKET
BY APPLICATION
7.1.2.1. MARKET
BY DEEP BRAIN STIMULATION
7.1.3. MARKET
BY DETECTION AND PREDICTION DEVICE TYPE
7.1.4. MARKET
BY END-USER
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. UNITED
STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET
BY DEVICE TYPE
7.2.1.1. MARKET
BY WEARABLE DEVICES
7.2.2. MARKET
BY APPLICATION
7.2.2.1. MARKET
BY DEEP BRAIN STIMULATION
7.2.3. MARKET
BY DETECTION AND PREDICTION DEVICE TYPE
7.2.4. MARKET
BY END-USER
7.2.5. COUNTRY
ANALYSIS
7.2.5.1. UNITED
KINGDOM
7.2.5.2. GERMANY
7.2.5.3. FRANCE
7.2.5.4. ITALY
7.2.5.5. SPAIN
7.2.5.6. REST
OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET
BY DEVICE TYPE
7.3.1.1. MARKET
BY WEARABLE DEVICE
7.3.2. MARKET
BY APPLICATION
7.3.2.1. MARKET
BY DEEP BRAIN STIMULATION
7.3.3. MARKET
BY DETECTION AND PREDICTION DEVICE TYPE
7.3.4. MARKET
BY END-USER
7.3.5. COUNTRY
ANALYSIS
7.3.5.1. CHINA
7.3.5.2. JAPAN
7.3.5.3. INDIA
7.3.5.4. SOUTH
KOREA
7.3.5.5. ASEAN COUNTRIES
7.3.5.6. AUSTRALIA
& NEW ZEALAND
7.3.5.7. REST
OF ASIA-PACIFIC
7.4. LATIN
AMERICA
7.4.1. MARKET
BY DEVICE TYPE
7.4.1.1. MARKET
BY WEARABLE DEVICE
7.4.2. MARKET
BY APPLICATION
7.4.2.1. MARKET
BY DEEP BRAIN STIMULATION
7.4.3. MARKET
BY DETECTION AND PREDICTION DEVICE TYPE
7.4.4. MARKET
BY END-USER
7.4.5. COUNTRY
ANALYSIS
7.4.5.1. BRAZIL
7.4.5.2. MEXICO
7.4.5.3. REST
OF LATIN AMERICA
7.5. MIDDLE
EAST AND AFRICA
7.5.1. MARKET
BY DEVICE TYPE
7.5.1.1. MARKET
BY WEARABLE DEVICES
7.5.2. MARKET
BY APPLICATION
7.5.2.1. MARKET
BY DEEP BRAIN STIMULATION
7.5.3. MARKET
BY DETECTION AND PREDICTION DEVICE TYPE
7.5.4. MARKET
BY END-USER
7.5.5. COUNTRY
ANALYSIS
7.5.5.1. UNITED
ARAB EMIRATES
7.5.5.2. SAUDI
ARABIA
7.5.5.3. TURKEY
7.5.5.4. SOUTH
AFRICA
7.5.5.5. REST
OF MIDDLE EAST & AFRICA
8. COMPETITIVE
LANDSCAPE
8.1. LIVANOVA
PLC
8.2. NATUS
MEDICAL INCORPORATED
8.3. CADWELL
INDUSTRIES INC
8.4. NIHON
KOHDEN CORPORATION
8.5. COMPUMEDICS
LIMITED
8.6. MEDTRONIC
PLC
8.7. BOSTON
SCIENTIFIC CORPORATION
8.8. EMPATICA
INC
8.9. KONINKLIJKE
PHILIPS NV
8.10. NEUROPACE
INC
8.11. DRÄGERWERK
AG & CO KGAA
8.12. SHENZHEN
MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
8.13. NEUROSOFT
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: GLOBAL EPILEPSY
DEVICES MARKET, BY REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: LIST OF
COLLABORATIONS
TABLE 6: LIST OF ACQUISITIONS
TABLE 7: EXAMPLES OF
ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES
TABLE 8: EXAMPLE OF MOBILE EEG
DEVICES
TABLE 9: GLOBAL EPILEPSY
DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: GLOBAL EPILEPSY
DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
TABLE 11: GLOBAL EPILEPSY
DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 12: GLOBAL EPILEPSY
DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 13: GLOBAL EPILEPSY
DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN $
MILLION)
TABLE 14: GLOBAL EPILEPSY
DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 15: GLOBAL EPILEPSY
DEVICES MARKET, BY REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 17: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 18: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
TABLE 19: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 20: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 21: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN
$ MILLION)
TABLE 22: NORTH AMERICA
EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 23: EUROPE EPILEPSY
DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 24: EUROPE EPILEPSY
DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 25: EUROPE EPILEPSY
DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
TABLE 26: EUROPE EPILEPSY
DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 27: EUROPE EPILEPSY
DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 28: EUROPE EPILEPSY
DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN $
MILLION)
TABLE 29: EUROPE EPILEPSY
DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 30: ASIA-PACIFIC EPILEPSY
DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 31: ASIA-PACIFIC
EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 32: ASIA-PACIFIC
EPILEPSY DEVICES MARKET, BY WEARABLE DEVICE, 2022-2028 (IN $ MILLION)
TABLE 33: ASIA-PACIFIC
EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 34: ASIA-PACIFIC
EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 35: ASIA-PACIFIC
EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN
$ MILLION)
TABLE 36: ASIA-PACIFIC
EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 37: LATIN AMERICA
EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 38: LATIN AMERICA
EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 39: LATIN AMERICA
EPILEPSY DEVICES MARKET, BY WEARABLE DEVICE, 2022-2028 (IN $ MILLION)
TABLE 40: LATIN AMERICA
EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 41: LATIN AMERICA
EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 42: LATIN AMERICA
EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN
$ MILLION)
TABLE 43: LATIN AMERICA
EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 44: MIDDLE EAST AND
AFRICA EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 45: MIDDLE EAST AND
AFRICA EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 46: MIDDLE EAST AND
AFRICA EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
TABLE 47: MIDDLE EAST AND
AFRICA EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 48: MIDDLE EAST AND
AFRICA EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $
MILLION)
TABLE 49: MIDDLE EAST AND
AFRICA EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE,
2022-2028 (IN $ MILLION)
TABLE 50: MIDDLE EAST AND
AFRICA EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
FIGURE
1: KEY BUYING IMPACT ANALYSIS
FIGURE
2: MARKET ATTRACTIVENESS INDEX
FIGURE
3: INDUSTRY COMPONENTS
FIGURE
4: GLOBAL EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2021 & 2028 (IN %)
FIGURE
5: GLOBAL EPILEPSY DEVICES MARKET, BY TRADITIONAL DEVICES, 2022-2028 (IN $
MILLION)
FIGURE
6: GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $
MILLION)
FIGURE
7: GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2021 & 2028 (IN %)
FIGURE
8: GLOBAL EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2028 (IN $ MILLION)
FIGURE
9: GLOBAL EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2028 (IN $ MILLION)
FIGURE
10: GLOBAL EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2028 (IN $ MILLION)
FIGURE
11: GLOBAL EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2028 (IN $
MILLION)
FIGURE
12: GLOBAL EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2028 (IN
$ MILLION)
FIGURE
13: GLOBAL EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2028 (IN $
MILLION)
FIGURE
14: GLOBAL EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2028 (IN $
MILLION)
FIGURE
15: GLOBAL EPILEPSY DEVICES MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE
16: GLOBAL EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2028 (IN $
MILLION)
FIGURE
17: GLOBAL EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $
MILLION)
FIGURE
18: GLOBAL EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2021 & 2028
(IN %)
FIGURE
19: GLOBAL EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2028 (IN $
MILLION)
FIGURE
20: GLOBAL EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2028 (IN $ MILLION)
FIGURE
21: GLOBAL EPILEPSY DEVICES MARKET, BY ACCELEROMETER, 2022-2028 (IN $ MILLION)
FIGURE
22: GLOBAL EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2028
(IN $ MILLION)
FIGURE
23: GLOBAL EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE,
2021 & 2028 (IN %)
FIGURE
24: GLOBAL EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2028 (IN $
MILLION)
FIGURE
25: GLOBAL EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2028 (IN $
MILLION)
FIGURE
26: GLOBAL EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2028 (IN
$ MILLION)
FIGURE
27: GLOBAL EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2028 (IN $
MILLION)
FIGURE
28: GLOBAL EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2028 (IN $
MILLION)
FIGURE
29: GLOBAL EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2028 (IN $
MILLION)
FIGURE
30: GLOBAL EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2028
(IN $ MILLION)
FIGURE
31: GLOBAL EPILEPSY DEVICES MARKET, BY OTHER PREDICTION AND DETECTION DEVICE
TYPES, 2022-2028 (IN $ MILLION)
FIGURE
32: GLOBAL EPILEPSY DEVICES MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE
33: GLOBAL EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2028 (IN $
MILLION)
FIGURE
34: GLOBAL EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2028 (IN $
MILLION)
FIGURE
35: GLOBAL EPILEPSY DEVICES MARKET, BY HOMECARE SETTINGS, 2022-2028 (IN $
MILLION)
FIGURE
36: GLOBAL EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2028 (IN $
MILLION)
FIGURE
37: GLOBAL EPILEPSY DEVICES MARKET, BY REGIONAL OUTLOOK, 2021 & 2028 (IN %)
FIGURE
38: UNITED STATES EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
39: CANADA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
40: UNITED KINGDOM EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
41: GERMANY EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
42: FRANCE EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
43: ITALY EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
44: SPAIN EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
45: REST OF EUROPE EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
46: CHINA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
47: JAPAN EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
48: INDIA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
49: SOUTH KOREA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
50: ASEAN COUNTRIES EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
51: AUSTRALIA & NEW ZEALAND EPILEPSY DEVICES MARKET 2022-2028 (IN $
MILLION)
FIGURE
52: REST OF ASIA-PACIFIC EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
53: BRAZIL EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
54: MEXICO EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
55: REST OF LATIN AMERICA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
56: UNITED ARAB EMIRATES EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
57: SAUDI ARABIA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
58: TURKEY EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
59: SOUTH AFRICA EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
60: REST OF MIDDLE EAST & AFRICA EPILEPSY DEVICES MARKET 2022-2028 (IN $
MILLION)